glp 1 pen tirzepatida 💊 Tirzepatide — Mechanism of Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors Slimming pens face coverage hurdle

Across the UAE and globally, a new category of treatments often referred to as weight loss pills, including oral semaglutide and related GLP-1 medications, is changing how doctors approach obesity

GLP-1 is a natural hormone that helps control appetite by slowing digestion and increasing feelings of fullness

In the optimal binomial model, there was a significant main effect of Time i.e., weekend vs

Energy levels should be normalized, and appetite should feel more predictable

References Michaelides C

1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones